After finishing at $4.49 in the prior trading day, Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $4.48, down -0.22%. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 1397862 shares were traded.
Ratios:
Our goal is to gain a better understanding of MRSN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.77.
On February 29, 2024, Wedbush Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $2 to $7.
Guggenheim Upgraded its Neutral to Buy on February 29, 2024, while the target price for the stock was maintained at $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 16 ’24 when Protopapas Anna sold 29,399 shares for $2.71 per share. The transaction valued at 79,671 led to the insider holds 125,153 shares of the business.
Lowinger Timothy B sold 10,409 shares of MRSN for $28,208 on Jan 16 ’24. The SVP, Chief Sci.&Tech. Officer now owns 199,329 shares after completing the transaction at $2.71 per share. On Jan 16 ’24, another insider, DeSchuytner Brian, who serves as the SVP, COO & CFO of the company, sold 9,327 shares for $2.71 each. As a result, the insider received 25,276 and left with 54,511 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRSN now has a Market Capitalization of 543.44M and an Enterprise Value of 367.99M. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.75 while its Price-to-Book (P/B) ratio in mrq is 14.65. Its current Enterprise Value per Revenue stands at 9.98 whereas that against EBITDA is -2.22.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $9.62, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 4.2501, while the 200-Day Moving Average is calculated to be 2.5985.
Shares Statistics:
The stock has traded on average 2.33M shares per day over the past 3-months and 2.7M shares per day over the last 10 days, according to various share statistics. A total of 120.71M shares are outstanding, with a floating share count of 91.80M. Insiders hold about 24.32% of the company’s shares, while institutions hold 71.11% stake in the company. Shares short for MRSN as of Mar 15, 2024 were 8.73M with a Short Ratio of 3.75, compared to 7.1M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.19% and a Short% of Float of 7.83%.
Earnings Estimates
Its stock is currently analyzed by 7 different market analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.21, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.13 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.25 and -$0.87 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is -$0.72, with 7 analysts recommending between -$0.33 and -$0.91.
